Skip to main content
Premium Trial:

Request an Annual Quote

Cellectricon Inks Japan Distribution Deals

NEW YORK (GenomeWeb News) – Cellectricon today said that it has signed agreement with two firms to distribute its products in Japan.

The Mölndal, Sweden-based firm said that Novel Science will distribute its Dynaflow Resolve System, an add-on to patch-clamp setups for ion channel research. Nepa Gene will distribute Cellectricon's Cellaxess ACE System, a single electrode-based electroporation system that can be used for any adherent cell type.

"We are confident that these two leading distributors will help us expand our research and drug discovery systems into the rapidly growing Japanese market," Mattias Karlsson, VP of business development at Cellectricon, said in a statement.

Financial and other terms of the agreements were not disclosed.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.